Media Summary: Prof Eggermont speaks with ecancer at AACR 2018 about Prof Eggermont presents results at AACR 2018 from KEYNOTE-054, assessing disease Prof. Caroline Robert (Gustave Roussy, France) presents at ASCO 2017 the results of the KEYNOTE-006 study, showing ...
Reducing Recurrence Of Advanced Melanoma With Pembrolizumab - Detailed Analysis & Overview
Prof Eggermont speaks with ecancer at AACR 2018 about Prof Eggermont presents results at AACR 2018 from KEYNOTE-054, assessing disease Prof. Caroline Robert (Gustave Roussy, France) presents at ASCO 2017 the results of the KEYNOTE-006 study, showing ... Jason Luke, MD, FACP, UPMC Hillman Cancer Center, Pittsburgh, PA, comments on updated results from the Phase III ... Jason J. Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, summarises the KEYNOTE-716 trial (NCT03553836) ... Jason Luke reports on key results from ESMO Congress 2021 on LBA3 -
Jason J. Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, discusses the results of the KEYNOTE-716 trial of ... Alexander M. Eggermont, MD, PhD, professor of Oncological Surgery and general director of Gustave Roussy Cancer Campus ... Alexander M. M. Eggermont, MD, PhD, director general of Gustave Roussy Cancer Campus Grand Paris in Villejuif, France, ... Prof Ribas presents the findings of a phase III trial, which showed Jason Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, provides an overview of the Phase III KEYNOTE-716 ... Reporting from AACR 2023, Jeffrey S. Weber presents the results from primary analysis of the KEYNOTE-942 trial, testing a ...
Dr Luke talks to ecancer at ASCO 2023 about a final analysis from the phase 3 KEYNOTE-716 study. This looked at distant ... Eric Whitman, MD, surgeon, Atlantic Health System, discusses the role and toxicities of Jeffrey S. Weber, MD, PhD; Omid Hamid, MD; Jason J. Luke, MD, FACP; Hussein Tawbi, MD, PhD; Robert Andtbacka, MD, CM; ... Omid Hamid, MD, The Angeles Clinic and Research Institute, Los Angeles, CA, discusses the design and the findings from the ... This study pools patient cohorts from randomized and nonrandomized studies to investigate the association of Sebastian Kobold, MD, PhD, Ludwig-Maximilians-Universität München, Munich, Germany, provides an overview of his highlight of ...
Dr Sapna Patel speaks to ecancer at ESMO 2023 about the SWOG S1801 study which was for resectable stage 3 or
